enarzh-CNfrdehiitjakofaplptes
        Sign up  

Latest Projects and Scientific Studies

Actively Recruiting
ESCAPE NA-1

ESCAPE NA-1

To determine the efficacy of the neuro protctant NA-1 in reducing global disability in subjects with AIS with a small established infarct core and good collateral circulation selected for EVT.

The study is currently actively recruiting at multiple international sites! 

Read more

New Study
UNMASK EVT

UNMASK EVT

An international web-based survey to assess the decision to offer EVT. What factors and relative importance governs the selection for endovascular therapy (EVT) in real-world scenarios?

Read more

In Progress
TEMPO 2 Study

TEMPO 2 Study

To demonstrate the efficacy of using TNK-tPA to treat minor ischemic stroke in proven arterial occlusion.

A Phase 3, prospective, randomized controlled, open-­‐label with blinded outcome assessment (PROBE) controlled trial.

Read more

REPERFUSE

REPERFUSE

Acuate Quantitated T1 and T2 MRI of intra-arterial thrombolysis reperfusion related injury following stroke.

Read more

IDEF (NIH-NINDS)

IDEF (NIH-NINDS)

The focus of this study is to evaluate the investigational drug, deferoxamine mesylate or deferoxamine. This drug removes iron. Blood in the brain after a brain hemorrhage contains iron and this iron damages the brain. We are studying whether removal of iron from the brain hemorrhage will reduce the effects of the brain hemorrhage. We will look specifically at a person’s ability to function well and to think well after a brain hemorrhage. We will also learn more about the safety of the investigational drug.

Read more

POINT

POINT

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Read more

DATAS II

DATAS II

Establish the safety of early anticoagulation with the novel oral anticoagulant dabigatran in acute cerebrovascular syndrome patients.

Identify the rate of both symptomatic and asymptomatic hemorrhagic transformation (HT) associated with these treatments.

Identify predictors of HT associated with acute dabigatran treatment.

Hypothesis: The Investigators hypothesize that symptomatic HT rates in dabigatran and ASA treated patients will not be significantly different.

Read more

PREVENT

PREVENT

A multicenter randomized, double blind placebo controlled trial to determine the efficacy of long-term, low dose warfarin in the secondary prevention of venous thromboembolism.

Read more

  • Projects